| Teva Pharma AG - Piperacillin/Tazobactam-Teva 2.25 g, Pulver zur Herstellung einer Infusionslösung |
| 68062 | | 01 | | Piperacillin/Tazobactam-Teva 2.25 g | | Pulver zur Herstellung einer Infusionslösung | | J01CR05 | | Piperacillin and Beta-Lactamase Inhibitor | | 01.09.2020 | | |
|
| Composition |
| Praeparatio cryodesiccata: piperacillinum 2 g ut piperacillinum natricum, tazobactamum 0.25 g ut tazobactamum natricum, pro vitro. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | Lyophilisate | | | | | | Active Agent | Dose |
|---|
| Piperacilline | 2 g | | Tazobactame | 0.25 g |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | PR | PR | A | | Yes |
|
